Beth King: What Makes Stago Different From Every Other Vendor in Hemostasis?
Beth King, Portfolio Partnership Executive at Stago, shared a post on LinkedIn:
”What makes Stago different from every other vendor in hemostasis?
1. Hemostasis is all we do.
It isn’t one part of a larger diagnostics portfolio—it is our focus. We take coagulation seriously, and that commitment shows in our instrumentation, reagents, service, support, and expertise.
2. Our people make the difference.
From our sales team and applications specialists to our service engineers and leadership, we are dedicated to our customers and their laboratories. Many of us come from the laboratory ourselves, so we understand the challenges laboratorians face every day.
3. We make coagulation simpler.
Our goal is to help laboratories work efficiently, confidently, and accurately—without unnecessary complexity.
4. Our technology truly sets us apart.
Stago’s mechanical, viscosity-based clot detection is not dependent on optical clot detection. That means hemolysis, icterus, and lipemia do not create the same interference challenges associated with photometric systems.
Your staff should not have to spend valuable time interpreting questionable clot curves or wondering whether the appearance of a sample is preventing them from obtaining the critical coagulation result a patient needs.
That is the Stago Difference.
We are Stago 3.0.
Make it simple.
Make it Stago.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion
-
Oct 18, 2026, 12:14Abhi Kapuria: When VTE Prophylaxis Breaks Down in the ICU
-
Oct 18, 2026, 11:37Lee Anne Sorto: Beyond Compliance – Making Audits Count in Transfusion Safety